Sign inJoin waitlistJoin the waitlist

Lance Pagliaro

Professor of Oncology · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology and Medical Oncology
1990–1993
Internal Medicine
George Washington University School of Medicine
1987–1990
Albany Medical College
1983–1987
Amherst College
1979–1983

Research

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · JAMA Oncology · 2019 · 739 citations
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 496 citations
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
Journal of Clinical Oncology · 2004 · 392 citations

Christopher Logothetis
30 papers
Nizar Tannir
29 papers
Shi-Ming Tu
26 papers
Brian Costello
25 papers
Curtis Pettaway
24 papers
Stephen Boorjian
24 papers
PS
Philippe Spiess
21 papers · 1 as a resident
Eric Jonasch
17 papers
RM
Randall Millikan
16 papers
John Cheville
15 papers
Bradley Leibovich
12 papers
Jacob Orme
12 papers · 4 as a fellow

Grants

p53 Gene Therapy for Locally Advanced Bladder Cancer
National Cancer Institute · R21
Contact PI · $290.8K · University of Tx Md Anderson Can Ctr
1999–2000

Clinical trials

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Principal investigator · Recruiting · Phase 2
Mayo Clinic
2023–2028
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery
Principal investigator · Terminated · Phase 2
Academic and Community Cancer Research United
2018–2021
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2007–2015
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
1999–2010